DaVita (DVA) PT Lowered to $60 at SunTrust
Tweet
Share
E-mailGet Alerts DVA Hot Sheet
Price: $175.24 -1.15%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
SunTrust analyst David MacDonald lowered the price target on DaVita (NYSE: DVA) to $60.00 (from $68.00) while maintaining a Hold rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
